Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Biomarkers
Filter     Order     Display # 
Date Item Title
14 Apr 2008 Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
20 Mar 2008 Vermillion Announces Positive Results From Clinical Trial of Ovarian Tumor Triage Test; Study Meets Primary Endpoints
16 Nov 2007 The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma
16 Oct 2007 Celera and Collaborators Identify a Five-gene Genetic Risk Score(TM) that Predicts Risk of Coronary Heart Disease
03 Aug 2007 GTC Biotherapeutics and LFB Biotechnologies developing CD20 Antibody
17 Jul 2007 PreMD Signs Marketing and Distribution Agreement with AstraZeneca
29 May 2007 Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study
24 May 2007 Organon and Philips team up to study drug effects at the molecular level
13 Apr 2007 Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
20 Mar 2007 Miraculins announces positive results in pivotal prostate cancer biomarker study
21 Oct 2006 New antibody based diagnostic imaging agent demon-strates 100 % positive predictive accuracy in feasibility study
17 Oct 2006 Ciphergen Presents Data at IGCS Supporting Use of Protein Biomarkers to Discriminate Malignant From Benign Pelvic Disease
14 Oct 2006 EDP Biotech Debuts CA1-18 Tumor Marker Assay for Early Stage Colorectal Cancer
03 Oct 2006 Serum HER-2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy
20 Sep 2006 Independent Analysis Of Eortc Trial Confirms Survival Impact Of Biomarker Identified In Phase 3 Trial Of Genasense(R) In Melanoma
21 Aug 2006 Agendia's MammaPrint(R) Shows Significant Agreement With Other Multi-Gene Breast Cancer Prognosis Tests
07 Aug 2006 Epigenomics AG Enters into Agreement with Johnson & Johnson Pharmaceutical Researach & Development, L.L.C
03 Aug 2006 Med BioGene reports promising pre-clinical results of its Diagnostic Lymphoma DNA Bioarray; biomarkers effective in diagnosing major lymphoma subtypes
03 Aug 2006 Response Biomedical Initiates US Clinical Trials of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
19 Jul 2006 Ciphergen Reports Biomarkers of Alzheimer's Disease
11 Jul 2006 Ciphergen Reports Discovery of Novel Biomarkers Linked to Pre-Eclampsia
05 Jul 2006 Epigenomics AG Presents New Clinical Data on Colorectal Cancer Screening Markers
05 Jul 2006 Agendia to develop commercial genetic profile
25 Jun 2006 Researchers Find Evidence of Potential Markers for Cardiovascular Disease in Hypogonadal Type 2 Diabetes Patients
08 Jun 2006 Bayer serum HER-2/neu change predicts clinical outcome to trastuzumab-based therapy
08 Jun 2006 Blood-based detection of colon and prostate cancer abstracts presented at American Society of Clinical Oncology Annual MeetingBlood-based detection of colon and prostate cancer abstracts presented at American Society of Clinical Oncology Annual Meeting
08 Jun 2006 Large, Randomized Study Confirms HPV Testing Is More Sensitive Than Both Conventional and Liquid-Based Pap Test
06 Jun 2006 Genomic Health, Inc. Announces Positive Results in Multiple Studies Presented at the American Society of Clinical Oncology Meeting
06 Jun 2006 New Data on Lung Cancer Trials with Targretin® is Presented at ASCO; Biomarker Data Analysis Supports Benefit in Subsets of Patients in 1st and 3rd Line NSCLC
06 Jun 2006 Ciphergen Reports Positive Results From Multi-Center Validation Ovarian Cancer Biomarker Study Results Presented at the Annual Meeting of the American Society of Clinical Oncology
06 Jun 2006 MacroArray Technologies Presents Data on a Diagnostic Test for Prostatic Intraepithelial Neoplasia (PIN) at 2006 ASCO Annual Meeting
05 Jun 2006 The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. Announce Positive Early Results in Development of Genomic Test for Colon Cancer Prognosis
04 Jun 2006 Lilly Breast Cancer Studies Explore Potential Role of Pharmacogenomics in Customizing Chemotherapy
03 Jun 2006 Serum HER-2/neu Change Predicts Clinical Outcome To Trastuzumab-Based Therapy
01 Jun 2006 Miraculins Successfully Verifies Colorectal Biomarker Results
23 May 2006 Matritech's NMP22(R) BladderChek(R) Test Could Save Lives and Reduce Expense in Screening High Risk Populations for Bladder Cancer
23 May 2006 Study identifies predictors of bipolar disorder risk
23 May 2006 Prostate-Specific Membrane Antigen (PSMA) Expression in Neovasculature Associated with Renal Cell Carcinoma is Characterized
22 May 2006 New Study Demonstrates That Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Prostate Cancer Recurrence
18 May 2006 Clinical Benefits of UroVysion® DNA Test Highlighted by Bladder Cancer Experts in Urology
17 May 2006 Improved recognition of prostate cancer with special test cPSA – fewer biopsies required
17 May 2006 Genzyme Releases Two New Molecular Tests for Acute Myelogenous Leukemia
12 May 2006 Celera and Collaborators Discover Genetic Markers Associated with Early-Onset Heart Attacks; Findings from Three Studies Involving 2,000 Individuals from Multiple Institutions Could Improve Understanding of Disease Mechanisms
08 May 2006 deCODE Discovers Major Genetic Risk Factor for Prostate Cancer
08 May 2006 deCODE Discovers Major Genetic Risk Factor for Prostate Cancer
03 May 2006 PPD to Discover Biomarkers for PDL BioPharma
27 Apr 2006 Chondrogene partners with Kaiser Permanente
27 Apr 2006 The cPSA test outperforms the tPSA test in specificity and positive predictive value
27 Apr 2006 Celera Announces Data Supporting a Predictor for Risk of Cirrhosis in Chronic Hepatitis C Patients; Research Studies Involving 1,500 Patient Samples from Multiple Institutions Show Clinical Utility of Cirrhosis Risk Score (tm)
12 Apr 2006 PreMD Achieves Goal of 5,000 Subjects in PREPARE Study
 
<< Start < Prev 1 2 Next > End >>
Results 1 - 50 of 79

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics